Crestline Management, L.P.: 13F holdings
CIK 15360542026Q2
| Positions | 3 |
|---|
| Reported value | $53.5m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 3 (+0 vs prior quarter) |
|---|
| Reported value | $53.5m (+15.6%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| DNLI DENALI THERAPEUTICS INC | 1,910,732 | $49.1m | 91.9% |
| SANA SANA BIOTECHNOLOGY INC | 755,736 | $2.6m | 4.9% |
| EGHT 8X8 INC NEW | 990,850 | $1.7m | 3.2% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1536054")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples